The expression of TLR9 in human cutaneous leishmaniasis is associated with granuloma

Parasite Immunology

Volumn 32, Issue 11-12, 2010, Pages 769-772

  Tuon, F F ^a   Fernandes, E R ^a   Pagliari, C ^a   Duarte, M I S ^a   Amato, V S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

American tegumentary leishmaniasis; Leishmania; Leishmaniasis; Toll like receptors

Indexed keywords

GAMMA INTERFERON; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ARTICLE; CYTOKINE PRODUCTION; DERMIS; DISEASE ASSOCIATION; DOWN REGULATION; GRANULOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; INTERMETHOD COMPARISON; KERATINOCYTE; LEISHMANIA BRAZILIENSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN LEISHMANIASIS;

DERMIS; EPIDERMIS; GENE EXPRESSION PROFILING; GRANULOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; TOLL-LIKE RECEPTOR 9;

LEISHMANIA BRAZILIENSIS;

EID: 78650431243     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2010.01243.x     Document Type: Article

References (14)

1. Li Y, Ishii K, Hisaeda H, et al. IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9? Gene Ther 2004; 11: 941-948.
2. Tuon FF, Amato VS, Bacha HA, et al. Toll-like receptors and leishmaniasis. Infect Immun 2008; 76: 866-872.
3. Barton GM & Medzhitov R. Toll-like receptor signaling pathways. Science 2003; 300: 1524-1525.
4. Becker I, Salaiza N, Aguirre M, et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol Biochem Parasitol 2003; 130: 65-74.
5. Schleicher U, Liese J, Knippertz I, et al. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med 2007; 204: 893-906.
6. Martinez-Salazar B, Berzunza-Cruz M & Becker I. [Leishmania mexicana DNA activates murine macrophages and increases their TLR9 expression]. Gac Med Mex 2008; 144: 99-104.
7. Amato VS, Tuon FF, De Andrade HF, et al. Immunohistochemistry and polymerase chain reaction on paraffin-embedded material improve the diagnosis of cutaneous leishmaniasis in the Amazon region. Int J Dermatol 2009; 48: 1091-1095.
8. Pagliari C & Sotto MN. Correlation of factor XIIIa+ dermal dendrocytes with paracoccidioidomycosis skin lesions. Med Mycol 2002; 40: 407-410.
9. Li J, Chen J, Tan Z, Liu H & Liu Z. Expression of TLR9 and its mRNA in the lesions of lichen planus. J Huazhong Univ Sci Technolog Med Sci 2007; 27: 203-205.
10. Jarrousse V, Quereux G, Marques-Briand S, Knol AC, Khammari A & Dreno B. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Eur J Dermatol 2006; 16: 636-641.
11. Bou Fakher FH, Rachinel N, Klimczak M, Louis J & Doyen N. TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions. J Immunol 2009; 182: 1386-1396.
12. Pivarcsi A. Toll-like receptor 9-independent suppression of skin inflammation by oligonucleotides. J Invest Dermatol 2007; 127: 746-748.
13. Tuon FF, Amato VS, Floeter-Winter LM, et al. Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids - first report. Int J Dermatol 2007; 46: 628-630.
14. Ito T, Schaller M, Hogaboam CM, et al. TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. J Clin Invest 2009; 119: 33-46.